Mumbai, Maharashtra, India, June 2026 — Ajay Jajoo has started a new position as Group Vice President & Global Corporate Controller at Glenmark Pharmaceuticals, bringing more than two decades of global finance leadership experience across the pharmaceutical, chemicals, metals, mining, and manufacturing sectors.
In his new role, Ajay will oversee global corporate finance, financial governance, reporting, controls, risk management, and strategic finance initiatives as Glenmark Pharmaceuticals continues its transformation journey focused on innovation-led growth and stakeholder value creation. His appointment comes at a significant phase for the company as it advances its science-based innovation strategy and strengthens its global operations.
Prior to joining Glenmark Pharmaceuticals, Ajay spent more than eight years with Deepak Phenolics Limited, where he progressed through several senior leadership positions including Vice President & CFO, Chief Financial Officer & Chief Risk Officer, and most recently President & CFO. During his tenure, he played a pivotal role in strengthening financial governance, enterprise risk management, business performance, strategic planning, and value creation initiatives that supported the company’s growth trajectory.
Before Deepak Phenolics, Ajay served as Deputy CFO at Vedanta Limited – Aluminium Business, where he led finance operations for one of India’s largest aluminium and power complexes, supporting financial strategy, operational excellence, governance, and business performance initiatives.
Earlier, he held the position of General Manager at Vedanta Resources Plc – Copper India, where he was responsible for business planning, enterprise risk management, financial reporting, governance frameworks, and strategic execution. His contributions supported complex industrial operations while ensuring compliance with international financial reporting standards and corporate governance requirements.
Ajay’s international leadership experience includes serving as Chief Financial Officer at Copper Mines of Tasmania in Australia, where he managed finance, taxation, business performance, and strategic planning functions within the mining sector.
He began his leadership journey with Sterlite Technologies Limited as Manager – Finance & Taxation, building a strong foundation in finance, taxation, compliance, and business operations that would shape his subsequent executive career.
Throughout his professional journey, Ajay has developed deep expertise in corporate finance, enterprise risk management, financial transformation, governance, strategic planning, business partnering, and stakeholder value creation across multinational organizations and complex business environments.
About Glenmark Pharmaceuticals
Glenmark Pharmaceuticals Limited is a research-led global pharmaceutical company committed to enriching lives through innovation and scientific advancement. Over the past four decades, the company has evolved from a generics-focused organization into a global healthcare enterprise offering branded, specialty, and over-the-counter products.
Glenmark has established a strong presence in key therapeutic areas including dermatology, respiratory care, and oncology, supported by ten state-of-the-art manufacturing facilities across four continents and operations in more than 80 countries. The company continues to strengthen its innovation capabilities through Ichnos Glenmark Innovation (IGI), an alliance focused on accelerating breakthrough therapies and advancing cancer treatment research.
Driven by its core values of Achievement, Respect, and Knowledge, Glenmark remains committed to innovation, sustainability, and creating long-term value for patients, healthcare systems, communities, and stakeholders worldwide.
Read Also : When HR “Produces Nothing”: A Response to Jennifer Sey’s Anti-HR Vision
The Fine Balance: Navigating Work, Life, and Mental Wellbeing
Mind the Leadership Gap – From Learning to Real-World Impact
How the Adecco Group is empowering its employees for the future of work
